Need and Potential of Antimicrobial Stewardship in Community Hospitals
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Preventing, reducing, and controlling the emergence of antimicrobial-resistant organisms is a major public health challenge requiring the participation of the entire medical community and public health agencies. Antimicrobial stewardship programs (ASPs) have the potential to integrate the many and sometimes disparate individuals and organizations that rely on antimicrobial agents in an effort to better control antimicrobial prescribing, possibly minimizing the emergence of resistant organisms. Developing and implementing ASPs can be a major challenge for community-based hospitals. In addition to specific and localized patterns of resistance-a consideration for every hospital-community hospitals must develop strategies that appropriately conform to their size, staffing, personnel, and infrastructure. This article reviews the ASP strategies and resources currently available to community hospitals for improving if, when, and how antimicrobial agents are prescribed and delivered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053 · cited 1×
“Outside the hospital, community-acquired methicillinresistant Staphylococcus aureus (MRSA) is now a leading cause of community-acquired skin and soft-tissue infections, including necrotizing fasciitis [7–13], and is also associated with community-acquired bacteremia, urinary tract infection (UTI), and pneumonia [8].”
BackgroundKing, M. D., Humphrey, B. J., Wang, Y. F., Kourbatova, E. V., Ray, S. M., & Blumberg, H. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00005 · Cited by 776
Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections
Moran, G. J., Amii, R. N., Abrahamian, F. M., & Talan, D. A. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1106.040641 · Cited by 278 · cited 1×
“Outside the hospital, community-acquired methicillinresistant Staphylococcus aureus (MRSA) is now a leading cause of community-acquired skin and soft-tissue infections, including necrotizing fasciitis [7–13], and is also associated with community-acquired bacteremia, urinary tract infection (UTI), and pneumonia [8].”
Background
Cited by
What is antimicrobial stewardship?
Dyar, O. J., Huttner, B., Schouten, J., & Pulcini, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.026 · Cited by 870
Schuts, E. C., Hulscher, M. E. J. L., Mouton, J. W., Verduin, C. M., Stuart, J. W. T. C., Overdiek, H. W. P. M., van der Linden, P. D., Natsch, S., Hertogh, C. M. P. M., Wolfs, T. F. W., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00065-7 · Cited by 758
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Hicks, L. A., Bartoces, M. G., Roberts, R. M., Suda, K. J., Hunkler, R. J., Taylor, T. H., & Schrag, S. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ076 · Cited by 559
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
Carlet, J., Jarlier, V., Harbarth, S., Voss, A., Goossens, H., Pittet, D., & Forum, T. P. O. T. 3. W. H.-A. I. (2012) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-1-11 · Cited by 350
Diverse Antibiotic Resistance Genes in Dairy Cow Manure
Wichmann, F., Udikovic-Kolic, N., Andrew, S., & Handelsman, J. (2014) · mBio · doi:10.1128/mbio.01017-13 · Cited by 287
de With, K., Allerberger, F., Amann, S., Apfalter, P., Brodt, H.-R., Eckmanns, T., Fellhauer, M., Geiss, H. K., Janata, O., Krause, R., et al. (2016) · Infection · doi:10.1007/s15010-016-0885-z · Cited by 215
“More recent publications also detail use of these programmes in intensive care units [13–15], paediatrics [16–18] or small community hospitals [19–21].”
Donà, D., Barbieri, E., Daverio, M., Lundin, R., Giaquinto, C., Zaoutis, T., & Sharland, M. (2020) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0659-3 · Cited by 199
Sartelli, M., C. Hardcastle, T., Catena, F., Chichom-Mefire, A., Coccolini, F., Dhingra, S., Haque, M., Hodonou, A., Iskandar, K., Labricciosa, F. M., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9080497 · Cited by 149
Metadata
- Authors
- Septimus, E. J., & Owens, R. C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08-15
- Volume
- 53
- Issue
- suppl_1
- Pages
- S8-S14
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2148774394
- Cited by
- 127
- References
- 6
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.